Matinas Biopharma Holdings, Inc. (NYSEAMERICAN:MTNB – Get Free Report)’s stock price dropped 0.4% during trading on Friday . The company traded as low as $0.7655 and last traded at $0.79. Approximately 19,355 shares traded hands during mid-day trading, a decline of 37% from the average daily volume of 30,777 shares. The stock had previously closed at $0.7929.
Matinas Biopharma Stock Down 0.4%
The company’s fifty day moving average price is $1.24 and its two-hundred day moving average price is $1.29. The company has a market cap of $5.06 million, a price-to-earnings ratio of -0.23 and a beta of 1.32.
Matinas Biopharma (NYSEAMERICAN:MTNB – Get Free Report) last announced its earnings results on Monday, November 10th. The company reported ($0.40) EPS for the quarter.
Matinas Biopharma Company Profile
Matinas BioPharma Holdings, Inc is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D.
Featured Articles
- Five stocks we like better than Matinas Biopharma
- Best Stocks Under $10.00
- Dave & Buster’s Reversal Is in PLAY After Double-Bottom Breakout
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Finance Stocks to Buy on Rising 10-Year Treasury Rates
- How to Calculate Options Profits
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
Receive News & Ratings for Matinas Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
